Zhaoyang Doctor Received $7.2 Million In Series A2 Financing

According to 36Kr, the mental health service platform Zhaoyang Doctor just received around 7.2 million dollars in Series A2 financing. This round of financing was led by 3E Bioventures, and followed by Guojin Capital. The funds will be used to expand offline offices around the country.

Zhaoyang Doctor was founded in 2015, is a platform for the diagnosis and treatment of mental health problems, both online and offline. The company also provides SaaS tool to connect patients and doctors, and physical clinics and drug stores. In addition to the diagnosis and treatment of psychiatric diseases, Zhaoyang Doctor also extended its business to the field of psychological counseling.

At present, the company's main income comes from drug sales; in the past year, the income of psychological counseling has gradually increased, and it has become a psychological service provider for listed companies such as Tencent and Vision. The platform has covered nearly 50% of first-line psychiatrists nationwide, and continues to maintain a monthly growth rate of 10%. The number of patients and prescriptions are increasing by nearly 20%.

In the future, Zhaoyang Doctor's income is a psychological counselor service; with the continuous accumulation of medical data, these data will serve many drug development companies, and create AI assistants to alleviate the burden on the doctors.

3E Bioventures is a venture capital firm specializing in growth capital, it mainly focuses on healthcare venture investment fund.

Guojin Capital Group is a venture capital firm specializing in early to middle stage investments. The firm also makes late-stage investments minorly. It seeks to invest mainly in the internet, pan-entertainment and education sectors.